price
EB
NYSE · EBS
Emergent BioSolutions Inc.
Healthcare · Drug Manufacturers - Specialty & Generic
$5.94
Up+$0.01 (+0.17%)
Updated Aug 28, 2026, 5:17 PM
SID Score
3.8/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 633.13M
- P/E ratio
- 8.22
- Dividend yield
- 0.00%
- 52-week range
- $4.36 – $9.66
- Volume
- 1.3M
- Avg. volume
- 1.09M
Price performance
EBS price history
1M range · 21 trading sessions · Daily adjusted prices
EBS closed at $5.94 after 21 trading sessions, down 18.18% for the selected period.
- Last close
- $5.94
- Period change
- -18.18%
- Period low
- $4.45
- Period high
- $7.57
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Aug 27, 2026 | $5.98 | $6.005 | $5.75 | $5.94 | 1.3M |
| Aug 26, 2026 | $5.56 | $6.00 | $5.55 | $5.97 | 1.17M |
| Aug 25, 2026 | $5.20 | $5.67 | $5.20 | $5.64 | 1.36M |
| Aug 24, 2026 | $5.02 | $5.22 | $5.00 | $5.18 | 871.18K |
| Aug 21, 2026 | $4.79 | $5.105 | $4.75 | $5.08 | 1.42M |
| Aug 20, 2026 | $4.88 | $4.935 | $4.58 | $4.82 | 1.51M |
| Aug 19, 2026 | $4.81 | $4.92 | $4.735 | $4.89 | 1.59M |
| Aug 18, 2026 | $4.46 | $4.67 | $4.46 | $4.66 | 746.28K |
| Aug 17, 2026 | $4.50 | $4.58 | $4.43 | $4.50 | 695.64K |
| Aug 14, 2026 | $4.50 | $4.67 | $4.45 | $4.59 | 1.1M |
| Aug 13, 2026 | $4.52 | $4.73 | $4.45 | $4.49 | 1.46M |
| Aug 12, 2026 | $4.42 | $4.64 | $4.38 | $4.55 | 1.7M |
| Aug 11, 2026 | $4.47 | $4.53 | $4.3699 | $4.45 | 1.76M |
| Aug 10, 2026 | $4.72 | $4.72 | $4.36 | $4.47 | 4.33M |
| Aug 7, 2026 | $5.40 | $5.55 | $4.81 | $4.84 | 3.14M |
| Aug 6, 2026 | $5.95 | $5.97 | $5.06 | $5.31 | 4.26M |
| Aug 5, 2026 | $7.64 | $7.70 | $7.52 | $7.54 | 729.02K |
| Aug 4, 2026 | $7.46 | $7.63 | $7.35 | $7.57 | 489.1K |
| Aug 3, 2026 | $7.38 | $7.415 | $7.20 | $7.41 | 441.01K |
| Jul 31, 2026 | $7.28 | $7.32 | $7.05 | $7.22 | 487.19K |
| Jul 30, 2026 | $7.32 | $7.45 | $7.19 | $7.26 | 472.19K |
Latest EBS news
The latest Smart Investors Daily articles mentioning EBS.
Stock researchCompany · Financials
Loading stock research…